Saxaplit 5 Tablet contains Saxagliptin (5mg), an advanced DPP-4 inhibitor used to manage type 2 diabetes mellitus. It helps the body increase insulin secretion and decrease glucagon release, thereby maintaining optimal blood sugar levels, particularly after meals.
Saxagliptin works by enhancing the activity of incretin hormones, leading to improved insulin sensitivity and better glycemic control without significant risk of hypoglycemia. It is often prescribed as monotherapy or in combination with other oral antidiabetic agents such as metformin.
Belonging to the antidiabetic and endocrinology segment, Saxaplit 5 Tablet plays a vital role in the long-term management of diabetes, promoting a balanced glucose profile and supporting overall metabolic health.
For distributors and franchise owners, Saxaplit 5 Tablet represents a high-demand PCD pharma franchise and third-party manufacturing opportunity. With diabetes cases rising steadily, offering Saxagliptin-based formulations ensures consistent market growth and profitability across India.
Common side effects may include headache, upper respiratory tract infection, sore throat, or mild gastrointestinal discomfort. Rarely, allergic reactions, pancreatitis, or joint pain may occur. Seek medical attention if severe abdominal pain or swelling develops.
Saxaplit 5 Tablet is indicated for the management of type 2 diabetes mellitus in adults to improve glycemic control when diet and exercise alone are insufficient. It may be used as monotherapy or in combination with other oral antidiabetic agents like Metformin or Sulfonylureas.
Take Saxaplit 5 Tablet exactly as prescribed, with or without food, preferably at the same time each day. Regular monitoring of blood glucose and HbA1c levels is recommended. Inform your doctor if you have kidney disease, pancreatitis, or are taking insulin or other antidiabetic medications.
Store Saxaplit 5 Tablet in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of the reach of children.